Clinical Trials Directory

Trials / Completed

CompletedNCT04931719

Comparing Efficacy of PRP Combined With Different Hyaluronan for the Treatment of Knee Osteoarthritis

Comparing Efficacy of Platelet-rich Plasma (PRP) Combined With Different Hyaluronan for the Treatment of Knee Osteoarthritis: a Randomized Control Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
95 (actual)
Sponsor
Kaohsiung Veterans General Hospital. · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Either PRP or HA is each effective for treating knee OA. However, the efficacy of combined PRP and HA injections remains unknown clinically.

Detailed description

Intraarticular plasma-rich platelet (PRP) or hyaluronic acid (HA) was each effective for knee osteoarthritis(OA). The efficacy of combined injections remains unknown. This study aimed to evaluate the efficacy of PRP combined with different hyaluronan for treating knee OA. In a prospective, randomized-controlled trial, 95 patients with Kellgren-Lawrence grade 2 knee OA were randomized to receive a single intraarticular Artz (10mg/ml) followed by PRP (N=48) into target knee or single HYAJOINT Plus (20mg/ml) injection followed by PRP (N=47). Primary outcome was the change from baseline in the visual analog scale (VAS) pain at 6 months. Secondary outcomes included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne index, single leg stance test (SLS), use of rescue analgesics and patient satisfaction.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTPRP+Artz groupThe patients in the PRP+Artz group received one intraarticular Artz injection (2.5 ml) followed consecutively by one intraarticular injection of PRP (3ml).
COMBINATION_PRODUCTPRP+ HYAJOINT Plus groupThe patients in the PRP+HYAJOINT Plus group received one intraarticular HYAJOINT Plus injection (3ml) followed by one intraarticular injection of PRP (3ml).

Timeline

Start date
2019-07-01
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2021-06-18
Last updated
2021-06-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04931719. Inclusion in this directory is not an endorsement.